Stock Ticker

  • Loading stock data...

OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP) making strides in the $7.1 billion prostate cancer treatment space

OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP), a biopharmaceutical company making strides in the $7.1 billion prostate cancer treatment space, has continued to show very strong action on the charts so far in 2017, up more than 100% in a little over five weeks of action. We have been closely watching the company this year, and can offer […]

OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP) Provides Positive Update on ProscaVax Data

OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP) has been one of our favorite new players in the $7.1 billion prostate cancer treatment market. The company just put out a new press release summarizing data that makes a strong case in the preparation of a coming Phase II trial of ProscaVax, which is OncBioMuneā€™s lead pipeline asset. As noted […]

Sign Up To Get Our Latest Stocks Alerts